SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jerryriti who wrote (1032)10/23/1999 1:54:00 AM
From: JF Quinnelly  Read Replies (1) of 1728
 
jerry, David's right regarding the court action this summer. It just meant that INCY failed to get the case dismissed, and it will now go to trial. As will the AFFX/Hyseq case. I hope the AFFX price action hasn't been based on the idea that they won the lawsuit, because it may turn out not to be the case. It's hard to say exactly what is driving the price at any particular time, however.

From what I can see there are several promising genechip/array technologies, with each having different strengths and weaknesses. It doesn't look like any one platform will be best for all applications. Gene testing should prove to be a very large field, so we may find several winners here. AFFX among them.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext